English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Sam Jackson | Apr 30, 2023

Ultromics CEO: FDA approval of AI-enhanced platform to detect cardiac amyloidosis 'emphasises the importance of this innovation'

Sam Jackson | Apr 28, 2023

Eleos Health introduces Eleos Outreach, an AI service to 'make a difficult and mentally draining job more manageable'

Patient Daily | Apr 27, 2023

People with Obesity Share Perspectives on Weight Loss and GLP-1 Medications in Survey from Ro and the Obesity Action Coalition

Patient Daily | Apr 27, 2023

Komodo Health Introduces MapEnhance To Accelerate Multidimensional Insights for Healthcare and Life Sciences

Mifeed | Apr 27, 2023

Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023

Patient Daily | Apr 27, 2023

Intra-Cellular Therapies to Host First Quarter 2023 Financial Results Conference Call and Webcast

Patient Daily | Apr 27, 2023

Digital therapeutics: at an inflection point

Patient Daily | Apr 27, 2023

Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023

Trending

Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth

Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’

Patient Daily | Aug 21, 2025

Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’

+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program

  • 1
  • 2
  • 3
  • 4
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily